or Try an Advanced Search...

    Technical Analysis for AZTR - Azitra Inc.

    Grade Last Price % Change Price Change
    F 1.69 4.97% 0.08
    AZTR closed up 4.97 percent on Friday, September 22, 2023, on 15 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong N/A Down Down
    Historical AZTR trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 4.97%
    180 Bearish Setup Bearish Swing Setup 4.97%
    Lower Bollinger Band Walk Weakness 4.97%
    Stochastic Reached Oversold Weakness 4.97%
    Wide Bands Range Expansion 4.97%
    Below Lower BB Weakness 4.97%
    Gapped Down Weakness 4.97%
    Older End-of-Day Signals for AZTR ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Bearish 180 Entry 3 days ago
    Fell Below Previous Day's Low 3 days ago
    Down 1% 3 days ago
    Up 1% 3 days ago
    Rose Above Lower Bollinger Band 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AZTR Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Molecular Biology Rare Diseases Epidermal Growth Factor Receptor Genodermatoses Skin Diseases Netherton Syndrome Ichthyosis Pre Clinical Biopharmaceutical Biotherapeutic Products

    Is AZTR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 14 Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates
    Jul 12 AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
    Jul 11 Azitra appoints co-founder Travis Whitfill as chief operating officer
    Jul 11 Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer
    Jun 21 Azitra, Inc. Announces Closing of Initial Public Offering
    Jun 16 Drug developer Azitra shares trade lower following $8M IPO
    Jun 16 Dermatology drug developer Azitra prices downsized IPO of 1.5M shares at $5
    Jun 15 Azitra, Inc. Announces Pricing of Initial Public Offering
    Jun 5 Dermatology drug developer Azitra set terms for proposed $12M IPO
    Jun 5 Azitra downsizes proposed IPO to $8M from $12M
    See more AZTR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.18
    52 Week Low 1.61
    Average Volume 12,282
    200-Day Moving Average 0.00
    50-Day Moving Average 2.67
    20-Day Moving Average 1.98
    10-Day Moving Average 1.83
    Average True Range 0.18
    RSI (14) 32.43
    ADX 57.11
    +DI 5.65
    -DI 35.73
    Chandelier Exit (Long, 3 ATRs) 1.76
    Chandelier Exit (Short, 3 ATRs) 2.14
    Upper Bollinger Bands 2.36
    Lower Bollinger Band 1.60
    Percent B (%b) 0.12
    BandWidth 38.33
    MACD Line -0.26
    MACD Signal Line -0.27
    MACD Histogram 0.0117
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.81
    Resistance 3 (R3) 1.80 1.74 1.79
    Resistance 2 (R2) 1.74 1.71 1.75 1.78
    Resistance 1 (R1) 1.72 1.69 1.73 1.73 1.78
    Pivot Point 1.66 1.66 1.67 1.67 1.66
    Support 1 (S1) 1.64 1.63 1.65 1.65 1.60
    Support 2 (S2) 1.58 1.61 1.59 1.60
    Support 3 (S3) 1.56 1.58 1.59
    Support 4 (S4) 1.57